ClinicalTrials.Veeva

Menu

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

University of California Irvine (UCI) logo

University of California Irvine (UCI)

Status

Enrolling

Conditions

Driver Mutation
Lung Cancer

Treatments

Diagnostic Test: Low Dose CT Scan

Study type

Interventional

Funder types

Other

Identifiers

NCT07062172
UCI 24-118 (Other Identifier)
6367

Details and patient eligibility

About

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.

Enrollment

1,753 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Cohort A:

Inclusion Criteria:

  • Current diagnosis of lung cancer with a driver mutation.
  • Known driver mutation (e.g. via NGS, PCR, IHC, FISH, RT-PCR etc.)
  • Able and willing to give informed consent.
  • Able and willing to complete the screening questionnaire.

Cohort A:

Exclusion Criteria:

  • There are no exclusion criteria for Cohort A.

Cohort B:

Inclusion Criteria:

  • Age 40 - 80.
  • Must have a first degree relative (mother, father, sibling, biological child) eligible for Cohort A. Note: Multiple first degree relatives of a Cohort A eligible participant may be approached for participation into the trial.
  • Smoked < 20 pack years; a. Pack years = numbers of packs per day × number of years smoked; b. One pack year is the equivalent of smoking an average of 20 cigarettes (1 pack) per day for a year.
  • Be able to undergo a low dose chest CT scan.
  • If an upper respiratory infection (pneumonia, COVID19, flu, etc.) occurred in the last 3 months, this infection must have resolved by time of enrollment.
  • Able and willing to provide informed consent.
  • Able and willing to comply with the protocol requirements

Cohort B:

Exclusion Criteria:

  • Previous history of lung cancers.
  • Symptoms suggestive of presence of current lung cancer, including (but not limited to): unexplained weight loss of over 15 pounds within the last 12 months or unexplained hemoptysis.
  • Pregnant at time of enrollment.
  • History of any type of cancer within 5 years, with the exception of in situ carcinomas and non-melanoma skin cancers (if excised).
  • Current smoker.
  • Smoked ≥ 20 pack years.
  • Had a chest CT scan within 1 year of study entry.

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1,753 participants in 1 patient group

Low Dose CT Scan of First Degree Relatives of Lung Cancer Patients
Experimental group
Description:
First degree relatives of patients with lung cancer with a known driver mutation will receive a low dose CT scan of the chest to screen for lung abnormality.
Treatment:
Diagnostic Test: Low Dose CT Scan

Trial contacts and locations

1

Loading...

Central trial contact

University of California Irvine Medical; Chao Family Comprehensive Cancer Center University of California, Irvine

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems